Craif’s Scientific Advisor & Co-Founder Yasui Introduces “Urinary MicroRNA-based Early Cancer Detection Using Nanowire-based Devices” in EUON
Craif and Omiya City Clinic Sign New Joint Study Agreement
Craif Launches Follow Up Study to Further Improve the Performance of miSignal™
Craif and Tokyo Medical University Hospital Start Two Joint Study
Craif Announces Extended Series B Funding
Craif Announces Office Move to Accommodate Accelerated Growth
Craif and Maruho starts a new joint study to search for disease biomarkers utilizing urinary miRNA
Craif and National Cancer Center Hospital sign new joint study agreement to develop a diagnosis method of solid tumors utilizing biological materials such as miRNAs in body fluids
Craif launches “miSignal™” series which enables early-stage cancer detection using urinary miRNA. The first test from the series will be for ovarian cancer available from 1st Feburary.
Craif and National Cancer Center Hospital East sign new joint research agreement to commence multicenter joint study investigating the effectiveness of urinary miRNA analysis in diagnosis and radiotherapy for squamous cell carcinoma of the head and neck and rectal cancer